Dr. Scott Eagon
Our research group focuses on the development of small molecule pharmaceuticals and probes, particularly those targeting infectious diseases and cancer. Students are involved in all aspects of drug synthesis and pre-clinical development. Our group is also interested in developing new synthetic methods to produce compounds quickly & with minimal purification in an effort to reduce development costs. Students majoring in Chemistry, Biochemistry, or related majors are welcome to join, but two quarters of organic chemistry lab are required to join due to the complexity of the chemistry involved. Students minoring in computer science or those with experience in Unix environments are also welcome to contribute to our in silico drug screening program. Current projects include the development of kinase-based chemotherapy agents, biological probes to better understand disease-related proteins, anti-malarials with novel modes of action targeting multi-drug resistant strains of Plasmodium falciparum, the development of host-orientated compounds to combat anthrax, the development of new classes of antibiotics, and in silico screening programs to discover new drug candidates for infectious diseases. Click the "Research Website" link for more information.